Saniona Plans Clinical Trial Application for Pediatric Epilepsy Drug in December

MT Newswires · 2d ago
05:40 AM EST, 11/06/2026 (MT Newswires) -- Saniona (SANION.ST) intends to file its clinical trial application for SAN2668, its investigational drug for severe pediatric epilepsies, by the end of December. The company will submit the application through the EU Clinical Trials Information System, according to a Friday release. The application follows preclinical and chemistry, manufacturing and controls required to support a phase 1 clinical study for the drug.